Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections especially against beta-lactamase producing strains

Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections : especially against beta-lactamase producing strains

Augpenin contains ticarcillin (TIPC) and clavulanic acid (CVA), at a ratio of 15:1. The beta-lactamase inhibitor, CVA, has been added to protect the TIPC from inactivation by beta-lactamase. To investigate the drug efficacy and safety against urinary tract infections (UTI), Augpenin was administered...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 39(1993), 8 vom: 15. Aug., Seite 777-82
1. Verfasser: Shiono, A (VerfasserIn)
Weitere Verfasser: Kurihara, J, Hayashi, M, Suzuki, T, Imai, K, Yamanaka, H, Takezawa, Y, Kiren, H, Okabe, K, Tomaru, Y
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1993
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Clavulanic Acids beta-Lactamase Inhibitors Clavulanic Acid 23521W1S24 beta-Lactamases EC 3.5.2.6 Ticarcillin F93UJX4SWT